RNS Number : 6870Q

Omega Diagnostics Group PLC

22 June 2020

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Publication of Shareholder Circular

Omega (AIM: ODX), the medical diagnostics company focused on CD4, food intolerance and COVID-19 testing, confirms that the Circular to Shareholders in respect of the Fundraising, announced on 19 June 2020, is now available on the Company's website here:

http://www.omegadiagnostics.com/Investor-Relations/Corporate-Information 

Contacts: 

Omega Diagnostics Group PLC	Tel: 01259 763 030
Bill Rhodes, Interim Non-Executive Chairman Colin King, Chief Executive	www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
finnCap Ltd	Tel: 020 7220 0500
Geoff Nash/Hannah Boros (Corporate Finance)
Camille Gochez (ECM)
Walbrook PR Limited	Tel: 020 7933 8780 or omega@walbrookpr.com
Paul McManus	Mob: 07980 541 893
Lianne Cawthorne	Mob: 07584 391 303

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

CIRXLLFLBQLFBBF